EcoR1 Capital, LLC - Aug 15, 2025 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Ordinary Shares (ADAP)

Filing Manager
EcoR1 Capital, LLC
Reporting Manager
EcoR1 Capital, LLC
Security
Adaptimmune Therapeutics PLC Ordinary Shares
Symbol
ADAP
Shares outstanding
1.57B shares
Disclosed Ownership
66M shares
Ownership
4.2%
Form type
SCHEDULE 13G/A
Date filed
8/19/2025, 06:32 PM
Date of event
Aug 15, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
EcoR1 Capital, LLC 4.2% 66M 0 66M /s/ Oleg Nodelman Manager
Oleg Nodelman 4.2% 66M 0 66M /s/ Oleg Nodelman Reporting person
EcoR1 Capital Fund Qualified, L.P. 4% 63.2M 0 63.2M /s/ Oleg Nodelman Manager of the General Partner, EcoR1 Capital, LLC